Recent ICU News
- SeaStar Medical to Webcast Fireside Chat at the H.C. Wainwright Global Investment Conference • GlobeNewswire Inc. • 09/05/2024 12:00:00 PM
- September 6, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against ICU • PR Newswire (US) • 09/05/2024 09:45:00 AM
- SeaStar Medical Strengthens Financial Position with Elimination of All Long-Term Debt • GlobeNewswire Inc. • 09/04/2024 12:30:00 PM
- The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of SeaStar Medical Holding Corporation(ICU) Shareholders • PR Newswire (US) • 08/29/2024 09:45:00 AM
- Shareholders that lost money on SeaStar Medical Holding Corporation(ICU) Urged to Join Class Action - Contact The Gross Law Firm to Learn More • PR Newswire (US) • 08/26/2024 09:45:00 AM
- SeaStar Medical Holding Corporation Sued for Securities Law Violations - Contact The Gross Law Firm Before September 6, 2024 to Discuss Your Rights - ICU • PR Newswire (US) • 08/22/2024 09:45:00 AM
- Shareholders of SeaStar Medical Holding Corporation Should Contact The Gross Law Firm Before September 6, 2024 to Discuss Your Rights - ICU • PR Newswire (US) • 08/19/2024 09:45:00 AM
- SeaStar Medical Holding Corporation Sued for Securities Law Violations - Contact The Gross Law Firm Before September 6, 2024 to Discuss Your Rights - ICU • PR Newswire (US) • 08/15/2024 09:45:00 AM
- SeaStar Medical Reports Second Quarter 2024 Financial Results and Provides a Business Update • GlobeNewswire Inc. • 08/13/2024 08:38:00 PM
- The Gross Law Firm Notifies SeaStar Medical Holding Corporation Investors of a Class Action Lawsuit and Upcoming Deadline • PR Newswire (US) • 08/08/2024 09:45:00 AM
- Class Action Filed Against SeaStar Medical Holding Corporation (ICU) Seeking Recovery for Investors - Contact The Gross Law Firm • PR Newswire (US) • 08/05/2024 09:45:00 AM
- Nuwellis Announces First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical’s QUELIMMUNE™ Therapy at Cincinnati Children’s • GlobeNewswire Inc. • 07/26/2024 01:00:00 PM
- First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical’s FDA-Approved QUELIMMUNE Therapeutic Device • GlobeNewswire Inc. • 07/23/2024 12:30:00 PM
- Nuwellis Marks First Commercial Sale of QUELIMMUNE™ Therapy to Cincinnati Children’s • GlobeNewswire Inc. • 07/17/2024 01:00:00 PM
- CMS Grants Category B Coverage for Adults with Acute Kidney Injury Enrolled in SeaStar Medical’s Selective Cytopheretic Device Pivotal Trial • GlobeNewswire Inc. • 07/16/2024 12:30:00 PM
- Edelson Lechtzin LLP Urges SeaStar Medical Holding Corporation (NASDAQ: ICU, ICUCW) Shareholders to Consult Legal Counsel About the Pending Securities Fraud Class Action • PR Newswire (US) • 07/12/2024 09:05:00 PM
- SeaStar Medical Ships First QUELIMMUNE Product Order to U.S. Distribution Partner • GlobeNewswire Inc. • 07/12/2024 12:30:00 PM
- SeaStar Medical Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules • GlobeNewswire Inc. • 07/11/2024 08:05:00 PM
- SeaStar Medical Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules • GlobeNewswire Inc. • 07/10/2024 01:00:00 PM
- SeaStar Medical Finalizes FDA Labeling Requirement for QUELIMMUNE, Paving the Way for First Commercial Sales as Humanitarian Use Device • GlobeNewswire Inc. • 07/03/2024 12:30:00 PM
- SeaStar Medical’s Selective Cytopheretic Device Featured in Two Presentations at the 42nd Vicenza Course AKI-CRT-ECOS and Critical Care Nephrology • GlobeNewswire Inc. • 06/11/2024 12:30:00 PM
- SeaStar Medical Strengthens Board of Directors and Transitions to Commercial-Stage Company • GlobeNewswire Inc. • 06/10/2024 12:30:00 PM
- Article in Nature Scientific Reports Describes Mechanism of Action of SeaStar Medical’s Selective Cytopheretic Device in the Immunomodulation of Excessive Inflammation • GlobeNewswire Inc. • 06/07/2024 12:30:00 PM
- SeaStar Medical Announces 25-for-1 Reverse Stock Split • GlobeNewswire Inc. • 06/06/2024 12:30:00 PM
- Manuscript Published on Multiorgan Failure Patients Treated with SeaStar Medical’s Selective Cytopheretic Device Who Achieved Transplant Eligibility • GlobeNewswire Inc. • 05/22/2024 12:30:00 PM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM
Element79 Gold Corp Announces 2024 Clover Work Plans & Nevada Portfolio Updates • ELMGF • Sep 10, 2024 11:00 AM
Nightfood Holdings Inc. Completes Major Step on Uplist Journey by Closing Strategic All-Stock Acquisition of CarryoutSupplies.com • NGTF • Sep 10, 2024 8:15 AM
Element79 Gold Corp. Announces Sale of 100% Interest in Elder Creek, North Mill Creek, and Elephant Projects to 1472886 B.C. Ltd. • ELEM • Sep 9, 2024 9:34 AM